Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emerald Health Therapeutics Inc EMHTF

Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.


OTCQB:EMHTF - Post by User

Post by Kevelleon Feb 08, 2018 10:42pm
320 Views
Post# 27531173

now it’s go, go, go again. Long emh! Friday Flyday,

now it’s go, go, go again. Long emh! Friday Flyday,

“We’ve got deals that are back on after two-and-a-half weeks. Everybody has been sitting on the sidelines, and now it’s go, go, go again,”  said Eric Foster, a partner at Dentons Canada LLP, who leads the law firm’s cannabis group.

“Effectively what it says is it’s business as usual…. They’ve said these are companies that are allowed to list in Canada, individual exchanges can make their own decisions as to whether to list these entities. Really it just increased the disclosure,” he added.

Companies will be required to disclose more information about potential risks related to their own U.S. operations and those of third-party partners. The CSA warned that companies that don’t comply with the enhanced disclosure rules could face punishment.

“We view this development positively for Canadian-listed companies with U.S. operations, as it significantly reduces their risk profile, and may be the spark investors need to take advantage of attractive valuation opportunities,” Russell Stanley, an analyst with Echelon Wealth Partners, wrote in a note to clients.

Bullboard Posts